These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15126536)

  • 1. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.
    Boulman N; Levy Y; Leiba R; Shachar S; Linn R; Zinder O; Blumenfeld Z
    J Clin Endocrinol Metab; 2004 May; 89(5):2160-5. PubMed ID: 15126536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S; Mollabashi M; Kerman SR
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is pentraxin 3 a new cardiovascular risk marker in polycystic ovary syndrome?
    Sari U; Kaygusuz I; Kafali H
    Gynecol Obstet Invest; 2014; 78(3):173-8. PubMed ID: 25011417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome?
    Gözdemir E; Kaygusuz I; Kafalı H
    Gynecol Obstet Invest; 2013; 75(3):196-202. PubMed ID: 23548757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.
    Moran LJ; Noakes M; Clifton PM; Wittert GA; Belobrajdic DP; Norman RJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2944-51. PubMed ID: 17504892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
    Talbott EO; Zborowski JV; Boudreaux MY; McHugh-Pemu KP; Sutton-Tyrrell K; Guzick DS
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6061-7. PubMed ID: 15579759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
    Karadağ C; Yoldemir T
    J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
    Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
    Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
    Erdoğan M; Karadeniz M; Alper GE; Tamsel S; Uluer H; Cağlayan O; Saygili F; Yilmaz C
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.
    Cakal E; Ustun Y; Engin-Ustun Y; Ozkaya M; Kilinç M
    Gynecol Endocrinol; 2011 Jul; 27(7):491-5. PubMed ID: 20626239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
    Morin-Papunen L; Rautio K; Ruokonen A; Hedberg P; Puukka M; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4649-54. PubMed ID: 14557435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A; Yetkin G
    Gynecol Endocrinol; 2006 Jun; 22(6):324-8. PubMed ID: 16785157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C; Pabuccu R; Berker B; Satiroglu H
    Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
    Glintborg D; Sidelmann JJ; Altinok ML; Mumm H; Andersen M
    Metabolism; 2015 Oct; 64(10):1272-8. PubMed ID: 26194691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W; Qiao J; Yang Y; Wang L; Li R
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.
    Tola EN; Yalcin SE; Dugan N
    Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():168-172. PubMed ID: 28535403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.